tiprankstipranks
Trending News
More News >
Sinopharm Group Co Class H (HK:1099)
:1099
Hong Kong Market

Sinopharm Group Co (1099) Financial Statements

Compare
6 Followers

Sinopharm Group Co Financial Overview

Sinopharm Group Co's market cap is currently HK$58.07B. The company's EPS TTM is HK$2.449; its P/E ratio is 7.60; and it has a dividend yield of 5.01%. Sinopharm Group Co is scheduled to report earnings on March 21, 2025, and the estimated EPS forecast is HK$1.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 584.51B¥ 596.57B¥ 552.15B¥ 521.05B¥ 456.41B
Gross Profit¥ 44.26B¥ 48.51B¥ 47.43B¥ 44.05B¥ 40.32B
Operating Income¥ 16.19B¥ 20.21B¥ 20.60B¥ 19.71B¥ 17.76B
EBITDA¥ 20.17B¥ 26.90B¥ 26.25B¥ 24.68B¥ 22.62B
Net Income¥ 7.05B¥ 9.05B¥ 14.35B¥ 13.06B¥ 12.10B
Balance Sheet
Cash & Short-Term Investments¥ 54.31B¥ 63.81B¥ 55.22B¥ 43.54B¥ 50.22B
Total Assets¥ 392.83B¥ 383.39B¥ 364.78B¥ 335.41B¥ 311.24B
Total Debt¥ 76.39B¥ 73.78B¥ 69.59B¥ 68.37B¥ 68.53B
Net Debt¥ 22.07B¥ 9.97B¥ 14.37B¥ 24.84B¥ 18.35B
Total Liabilities¥ 266.14B¥ 263.08B¥ 254.71B¥ 235.76B¥ 221.29B
Stockholders' Equity¥ 78.88B¥ 74.58B¥ 68.07B¥ 61.89B¥ 56.36B
Cash Flow
Free Cash Flow¥ 9.58B¥ 14.84B¥ 18.55B¥ 7.05B¥ 9.07B
Operating Cash Flow¥ 11.55B¥ 17.17B¥ 20.96B¥ 9.31B¥ 11.15B
Investing Cash Flow¥ -3.75B¥ -944.53M¥ -3.59B¥ -1.27B¥ -2.20B
Financing Cash Flow¥ -17.29B¥ -7.64B¥ -5.69B¥ -14.69B¥ 2.03B
Currency in CNY

Sinopharm Group Co Earnings and Revenue History

Sinopharm Group Co Debt to Assets

Sinopharm Group Co Cash Flow

Sinopharm Group Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis